Screener
PTC Therapeutics PTCT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Other long-term liabilities | 13,704 | 13,704 |
| Total liabilities | 3,049,569 | 3,104,080 |
| Stockholders’ deficit: | ||
| Common stock, $0.001 par value. Authorized 250,000,000 shares; issued and outstanding 82,882,024 shares at March 31, 2026. Authorized 250,000,000 shares; issued and outstanding 81,474,366 shares at December 31, 2025. | 81 | 80 |
| Additional paid-in capital | 2,778,026 | 2,748,335 |
| Accumulated other comprehensive income | 8,466 | 10,501 |
| Accumulated deficit | (2,967,038) | (2,964,229) |
| Total stockholders’ deficit | (180,465) | (205,313) |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's common stock?
- PTC Therapeutics (PTCT) reported common stock of $81K in Q1 2026.
- How has PTC Therapeutics's common stock changed year-over-year?
- PTC Therapeutics's common stock increased by 3.8% year-over-year, from $78K to $81K.
- What is the long-term trend for PTC Therapeutics's common stock?
- Over 5 years (2020 to 2025), PTC Therapeutics's common stock has grown at a 2.7% compound annual growth rate (CAGR), from $70K to $80K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about PTC Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude